Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications
- 10 April 2024
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 657, 124110
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences
- National Science Foundation
- National Institutes of Health (#P30GM122733)
This publication has 57 references indexed in Scilit:
- Ocular permeability, intraocular biodistribution of lipid nanocapsule formulation intended for retinal drug deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2023
- Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiolEuropean Journal of Pharmaceutical Sciences, 2022
- Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overviewPhytotherapy Research, 2021
- Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic painEuropean Journal of Pharmaceutical Sciences, 2021
- Biological effects of Cannabidiol on normal human healthy cell populations: Systematic review of the literatureBiomedicine & Pharmacotherapy, 2020
- Diversity of molecular targets and signaling pathways for CBDPharmacology Research & Perspectives, 2020
- Effect of surfactant concentration and sterilization process on intraocular pressure–lowering activity of Δ9-tetrahydrocannabinol-valine-hemisuccinate (NB1111) nanoemulsionsDrug Delivery and Translational Research, 2020
- The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosisInflammation Research, 2020
- Synthesis, characterization, release kinetics and toxicity profile of drug-loaded starch nanoparticlesInternational Journal of Biological Macromolecules, 2015
- Ocular Disposition of the Hemiglutarate Ester Prodrug of ∆9-Tetrahydrocannabinol from Various Ophthalmic FormulationsPharmaceutical Research, 2013